CAS 2097381-85-4

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide

CAS: 2097381-85-4

Formel: C₂₇H₃₃N₅O₄S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 523.6470

Ref: IN-DA01DDMJ

VH298

CAS: 2097381-85-4

VH298

Reinheit: 99%

Molekulargewicht: 523.66g/mol

Ref: 54-OR96976

VH-298

CAS: 2097381-85-4

VH-298

Reinheit: ≥98%

Molekulargewicht: 523.65g/mol

Ref: 54-BUP10105

VH 298

CAS: 2097381-85-4

Formel: C₂₇H₃₃N₅O₄S

Reinheit: >93.0%(HPLC)(qNMR)

Farbe und Form: White to Light yellow powder to crystal

Molekulargewicht: 523.65

Ref: 3B-V0208

VH-298

CAS: 2097381-85-4

VH-298 blocks VHL:HIF-α interaction, stabilizes HIF-α, and triggers hypoxic response differently by inhibiting VHL post-HIF-α PHD hydroxylation.

Formel: C₂₇H₃₃N₅O₄S

Reinheit: 99.17% - >99.99%

Farbe und Form: Solid

Molekulargewicht: 523.65

Ref: TM-TQ0121

VH 298

CAS: 2097381-85-4

A selective VHL inhibitor that stabilizes the hydroxylated form of HIF-α, resulting in upregulation of downstream target genes and proteins. Provides a tool for studying hypoxic signaling pathway.

Formel: C₂₇H₃₃N₅O₄S

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 523.65 g/mol

Ref: 3D-BV165083

VH-298

CAS: 2097381-85-4

Reinheit: 98%

Molekulargewicht: 523.225

Ref: 10-F864115